ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.10 Cr | - | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ORCHID PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.10 Cr |
| Mar2024 | - |
| Mar2023 | ₹3.23 Cr |
| Mar2022 | ₹3.23 Cr |
| Mar2021 | ₹3.23 Cr |
How is Deferred Tax Assets / Liabilities of ORCHID PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.10 Cr | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹3.23 Cr | 0.00 | |
| Mar2022 | ₹3.23 Cr | 0.00 | |
| Mar2021 | ₹3.23 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,555.3 Cr | 0.3% | -10.6% | -50% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 0.3% |
-10.6% |
-50% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses